Related Experiment Videos
Complement-dependent cellular cytotoxicity due to alternative pathway C3 activation by the target cell membrane
Cellular Immunology
|September 1, 1984
Summary
Human serum enhances lymphocyte cytotoxicity against tumor cells, particularly when aided by interferon. Complement component C3 activation on target cells likely facilitates this natural killing mechanism.
Area of Science:
- Immunology
- Cell Biology
- Complement System
Background:
- Cytotoxic activity of lymphocytes is crucial for immune surveillance.
- The role of serum components in modulating lymphocyte-mediated cytotoxicity is not fully understood.
- Interferon (IFN) is known to activate immune cells.
Purpose of the Study:
- To investigate the effect of human serum (HS) on lymphocyte cytotoxicity against Raji cells.
- To explore the influence of interferon (IFN) and serum components on this cytotoxic activity.
- To elucidate the role of the complement system, specifically C3, in lymphocyte-mediated killing.
Main Methods:
- Cytotoxicity assays using human blood lymphocytes and Raji cells.
- Inclusion of human serum (HS), hypogammaglobulinemic serum (HyS), heat-inactivated serum, and C3-depleted serum.
- Treatment of effector cells with interferon (IFN).
- Treatment of target Raji cells with IFN and assessment of lysis sensitivity.
Main Results:
- Human serum (HS) significantly augmented lymphocyte cytotoxicity against Raji cells.
- Interferon (IFN) activation of lymphocytes also enhanced cytotoxicity.
- C3-depleted serum was inefficient in augmenting cytotoxicity, suggesting C3's involvement.
- IFN treatment of Raji cells reduced their lysis sensitivity, an effect reversed by HS.
Conclusions:
- Human serum, particularly through C3 activation and deposition on target cells, facilitates lymphocyte recognition and lysis.
- These findings suggest a mechanism for the natural killing phenomenon involving complement activation.
- Serum components and IFN play significant roles in modulating cellular immune responses.